Identification and characterization of two splicing variants of human Noxa

Anticancer Research

Volumn 28, Issue 3 A, 2008, Pages 1667-1674

  Wang, Zhen ^a   Sun, Yi ^a,b  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Apoptosis; BH3; Noxa gene

Indexed keywords

ACTIN; ALPHA ACTIN; AMINO ACID; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETA ACTIN; BH3 PROTEIN; BORTEZOMIB; CYCLOHEXIMIDE; ETOPOSIDE; MESSENGER RNA; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN NOXA; PROTEIN P53;

APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CONTROLLED STUDY; EXON; GENE; GENETIC VARIABILITY; HALF LIFE TIME; HUMAN; HUMAN CELL; INTRON; NOXA GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; HELA CELLS; HUMANS; LEUPEPTINS; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 45949093051     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kerr JF, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
2. Wyllie AH, Kerr JF and Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306, 1980.
3. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
4. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556, 1980.
5. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
6. Salvesen GS and Dixit VM: Caspases: intracellular signaling by proteolysis. Cell 91: 443-446, 1997.
7. Cryns V and Yuan J: Proteases to die for. Genes Dev 12: 1551-1570, 1998.
8. Danial NN and Korsmeyer SJ: Cell death: critical control points. Cell 116: 205-219, 2004.
9. Reed JC, Jurgensmeier JM and Matsuyama S: Bel-2 family proteins and mitochondria. Bi ochim Biophys Acta 1366: 127-137, 1998.
10. Gross A, McDonnell JM and Korsmeyer SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999.
11. Martinou JC and Green DR: Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2: 63-67, 2001.
12. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM and Huang DC: Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17: 393-403, 2005.
13. Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ and Cheng EH: Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8: 1348-1358, 2006.
14. van Delft MF, Wei AH, Mason KD Vandenberg CJ, Chen L, Czabotar PE, Willis SN, Scott CL, Day CL, Cory S, Adams JM, Roberts AW and Huang DC: The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10: 389-399, 2006.
15. Czabotar PE, Lee EF, van Delft MF, Day CL, Smith BJ, Huang DC, Fairlie WD, Hinds MG and Colman PM: Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc Natl Acad Sci USA 104: 6217-6222, 2007.
16. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T and Tanaka N: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058, 2000.
17. Kim JY, Ann HJ, Ryu JH, Suk K and Park JH: BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J Exp Med 199: 113-124, 2004.
18. Villunger A, Michalak EM, Coultas L, Mullauer F, Böck G, Ausserlechner MJ, Adams JM and Strasser A: p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302: 1036-1038, 2003.
19. Naik E, Michalak EM, Villunger A, Adams JM and Strasser A: Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa. J Cell Biol 176: 415-424, 2007.
20. Fernandez Y, Verhaegen M, Miller TP, Rush JL, Steiner P, Opipari AW Jr, Lowe SW and Soengas MS: Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res 65: 6294-6304, 2005.
21. Perez-Galan P, Roue G, Villamor N, Montserrat E, Campo E and Colomer D: The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 107: 257-264, 2006.
22. Fribley AM, Evenchik B, Zeng Q, Park BK, Guan JY, Zhang H, Hale TJ, Soengas MS, Kaufman RJ and Wang CY: Proteasome inhibitor PS-341 induces apoptosis in cisplatin-resistant squamous cell carcinoma cells by induction of Noxa. J Biol Chem 281: 31440-31447, 2006.
23. Voortman J, Checinska A, Giaccone G, Rodriguez JA and Kruyt FA: Bortezomib, but not cisplatin, induces mitochondria-dependent apoptosis accompanied by up-regulation of noxa in the non-small cell lung cancer cell line NCI-H460. Mol Cancer Ther 6: 1046-1053, 2007.
24. Bockbrader KM, Tan M and Sun Y: A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells. Oncogene 24: 7381-7388, 2005.
25. Robinson M, Jiang P, Cui J, Li J, Wang Y, Swaroop M, Madore S, Lawrence TS and Sun Y: Global Genechip profiling to identify genes responsive to p53-induced growth arrest and apoptosis in human lung carcinomas. Cancer Biol Therapy 2: 406-415, 2003.
26. Hijikata M, Kato N, Sato T, Kagami Y and Shimotohno K: Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate- responsive gene that is highly expressed in an adult T-cell leukemia cell line. J Virol 64: 4632-4639, 1990.
27. Adams JM and Cory S: The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26: 1324-1337, 2007.
28. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, Joseph MK, Kitada S, Korsmeyer SJ, Kunzer AR, Letai A, Li C, Mitten MJ, Nettesheim DG, Ng S, Nimmer PM, O'Connor JM, Oleksijew A, Petros AM, Reed JC, Shen W, Tahir SK, Thompson CB, Tomaselli KJ, Wang B, Wendt MD, Zhang H, Fesik SW and Rosenberg SH: An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435: 677-681, 2005.